Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1970 1
1972 1
1973 1
1974 1
1976 2
1977 2
1978 2
1979 2
1980 2
1981 3
1982 4
1983 1
1984 2
1985 3
1986 2
1987 6
1988 4
1989 6
1990 2
1991 4
1992 10
1993 5
1994 7
1995 7
1996 6
1997 12
1998 16
1999 6
2000 4
2001 5
2002 9
2003 7
2004 11
2005 9
2006 13
2007 5
2008 9
2009 8
2010 4
2011 11
2012 13
2013 16
2014 15
2015 9
2016 12
2017 20
2018 15
2019 14
2020 10
2021 10
2022 11
2023 21
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

361 results

Results by year

Filters applied: Meta-Analysis, Randomized Controlled Trial. Clear all
Page 1
Acetazolamide in Acute Decompensated Heart Failure with Volume Overload.
Mullens W, Dauw J, Martens P, Verbrugge FH, Nijst P, Meekers E, Tartaglia K, Chenot F, Moubayed S, Dierckx R, Blouard P, Troisfontaines P, Derthoo D, Smolders W, Bruckers L, Droogne W, Ter Maaten JM, Damman K, Lassus J, Mebazaa A, Filippatos G, Ruschitzka F, Dupont M; ADVOR Study Group. Mullens W, et al. N Engl J Med. 2022 Sep 29;387(13):1185-1195. doi: 10.1056/NEJMoa2203094. Epub 2022 Aug 27. N Engl J Med. 2022. PMID: 36027559 Clinical Trial.
Successful decongestion occurred in 108 of 256 patients (42.2%) in the acetazolamide group and in 79 of 259 (30.5%) in the placebo group (risk ratio, 1.46; 95% confidence interval [CI], 1.17 to 1.82; P<0.001). ...Acetazolamide treatment was associated with higher …
Successful decongestion occurred in 108 of 256 patients (42.2%) in the acetazolamide group and in 79 of 259 (30.5%) in the placebo gr …
Acetazolamide for OSA and Central Sleep Apnea: A Comprehensive Systematic Review and Meta-Analysis.
Schmickl CN, Landry SA, Orr JE, Chin K, Murase K, Verbraecken J, Javaheri S, Edwards BA, Owens RL, Malhotra A. Schmickl CN, et al. Chest. 2020 Dec;158(6):2632-2645. doi: 10.1016/j.chest.2020.06.078. Epub 2020 Aug 5. Chest. 2020. PMID: 32768459 Free PMC article.
RESEARCH QUESTION: How efficacious is acetazolamide for sleep apnea, and is its effect modified by sleep apnea type or acetazolamide dose? ...Any study in which adults with OSA/CSA received oral acetazolamide vs no acetazolamide (control) that reported …
RESEARCH QUESTION: How efficacious is acetazolamide for sleep apnea, and is its effect modified by sleep apnea type or acetazolami …
Acetazolamide in Decompensated Heart Failure with Volume Overload trial (ADVOR): baseline characteristics.
Mullens W, Dauw J, Martens P, Meekers E, Nijst P, Verbrugge FH, Chenot F, Moubayed S, Dierckx R, Blouard P, Derthoo D, Smolders W, Ector B, Hulselmans M, Lochy S, Raes D, Van Craenenbroeck E, Vandekerckhove H, Hofkens PJ, Goossens K, Pouleur AC, De Ceuninck M, Gabriel L, Timmermans P, Prihadi EA, Van Durme F, Depauw M, Vervloet D, Viaene E, Vachiery JL, Tartaglia K, Ter Maaten JM, Bruckers L, Droogne W, Troisfontaines P, Damman K, Lassus J, Mebazaa A, Filippatos G, Ruschitzka F, Dupont M. Mullens W, et al. Eur J Heart Fail. 2022 Sep;24(9):1601-1610. doi: 10.1002/ejhf.2587. Epub 2022 Jul 12. Eur J Heart Fail. 2022. PMID: 35733283 Free article. Clinical Trial.
AIMS: To describe the baseline characteristics of participants in the Acetazolamide in Decompensated Heart Failure with Volume Overload (ADVOR) trial and compare these with other contemporary diuretic trials in acute heart failure (AHF). ...All participants received standa …
AIMS: To describe the baseline characteristics of participants in the Acetazolamide in Decompensated Heart Failure with Volume Overlo …
Acetazolamide to increase natriuresis in congestive heart failure at high risk for diuretic resistance.
Verbrugge FH, Martens P, Ameloot K, Haemels V, Penders J, Dupont M, Tang WHW, Droogné W, Mullens W. Verbrugge FH, et al. Eur J Heart Fail. 2019 Nov;21(11):1415-1422. doi: 10.1002/ejhf.1478. Epub 2019 May 9. Eur J Heart Fail. 2019. PMID: 31074184 Free article. Clinical Trial.
AIMS: To investigate the effects of acetazolamide on natriuresis, decongestion, kidney function and neurohumoral activation in acute heart failure (AHF). ...CONCLUSION: Addition of acetazolamide increases the natriuretic response to loop diuretics compared to an inc …
AIMS: To investigate the effects of acetazolamide on natriuresis, decongestion, kidney function and neurohumoral activation in acute …
Renal function and decongestion with acetazolamide in acute decompensated heart failure: the ADVOR trial.
Meekers E, Dauw J, Martens P, Dhont S, Verbrugge FH, Nijst P, Ter Maaten JM, Damman K, Mebazaa A, Filippatos G, Ruschitzka F, Tang WHW, Dupont M, Mullens W. Meekers E, et al. Eur Heart J. 2023 Oct 1;44(37):3672-3682. doi: 10.1093/eurheartj/ehad557. Eur Heart J. 2023. PMID: 37623428 Clinical Trial.
BACKGROUND AND AIMS: In the ADVOR trial, acetazolamide improved decongestion in acute decompensated heart failure (ADHF). Whether the beneficial effects of acetazolamide are consistent across the entire range of renal function remains unclear. ...Overall, natriuresi …
BACKGROUND AND AIMS: In the ADVOR trial, acetazolamide improved decongestion in acute decompensated heart failure (ADHF). Whether the …
Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial.
NORDIC Idiopathic Intracranial Hypertension Study Group Writing Committee; Wall M, McDermott MP, Kieburtz KD, Corbett JJ, Feldon SE, Friedman DI, Katz DM, Keltner JL, Schron EB, Kupersmith MJ. NORDIC Idiopathic Intracranial Hypertension Study Group Writing Committee, et al. JAMA. 2014 Apr 23-30;311(16):1641-51. doi: 10.1001/jama.2014.3312. JAMA. 2014. PMID: 24756514 Free PMC article. Clinical Trial.

Mean improvements in papilledema grade (acetazolamide: -1.31, from 2.76 to 1.45; placebo: -0.61, from 2.76 to 2.15; treatment effect, -0.70; 95% CI, -0.99 to -0.41; P < .001) and vision-related quality of life as measured by the National Eye Institute VFQ-25 (acetazo

…
Mean improvements in papilledema grade (acetazolamide: -1.31, from 2.76 to 1.45; placebo: -0.61, from 2.76 to 2.15; treatment effect, …
[Acetazolamide in acute heart failure].
Jolti M, Darbellay Farhoumand P, Carballo D, Carballo S. Jolti M, et al. Rev Med Suisse. 2023 Oct 25;19(847):2002-2006. doi: 10.53738/REVMED.2023.19.847.2002. Rev Med Suisse. 2023. PMID: 37878100 Clinical Trial. French.
A recent multicentric randomised controlled trial studied the administration of acetazolamide in addition to standard care with loop diuretics in the acute setting. There was a significantly faster decongestion, based on a pragmatic clinical score, with very few side effec …
A recent multicentric randomised controlled trial studied the administration of acetazolamide in addition to standard care with loop …
Acetazolamide for the prevention of acute mountain sickness--a systematic review and meta-analysis.
Ritchie ND, Baggott AV, Andrew Todd WT. Ritchie ND, et al. J Travel Med. 2012 Sep-Oct;19(5):298-307. doi: 10.1111/j.1708-8305.2012.00629.x. Epub 2012 Jul 30. J Travel Med. 2012. PMID: 22943270 Free article. Review.
Primary end point was difference in incidence of AMS between acetazolamide and placebo groups. RESULTS: Acetazolamide prophylaxis was associated with a 48% relative-risk reduction compared to placebo. ...One study found that adverse effects of acetazolamide w …
Primary end point was difference in incidence of AMS between acetazolamide and placebo groups. RESULTS: Acetazolamide prophyla …
Effects of acetazolamide on pulmonary artery pressure and prevention of high-altitude pulmonary edema after rapid active ascent to 4,559 m.
Berger MM, Sareban M, Schiefer LM, Swenson KE, Treff F, Schäfer L, Schmidt P, Schimke MM, Paar M, Niebauer J, Cogo A, Kriemler S, Schwery S, Pickerodt PA, Mayer B, Bärtsch P, Swenson ER. Berger MM, et al. J Appl Physiol (1985). 2022 Jun 1;132(6):1361-1369. doi: 10.1152/japplphysiol.00806.2021. Epub 2022 May 5. J Appl Physiol (1985). 2022. PMID: 35511718 Free article. Clinical Trial.
Acetazolamide prevents acute mountain sickness (AMS) by inhibition of carbonic anhydrase. ...Our data do not support recommending acetazolamide for HAPE prevention....
Acetazolamide prevents acute mountain sickness (AMS) by inhibition of carbonic anhydrase. ...Our data do not support recommending …
Acetazolamide for acute kidney injury in patients undergoing high dose methotrexate therapy: a systematic review and meta-analysis.
Truong HH, Reddy S, Charkviani M, Nikravangolsefid N, Ninan J, Hassett L, Kashani KB, Domecq JP. Truong HH, et al. J Nephrol. 2024 May;37(4):911-922. doi: 10.1007/s40620-023-01850-2. Epub 2024 Jan 24. J Nephrol. 2024. PMID: 38265601 Review.
Furthermore, our meta-analysis showed that acetazolamide did not reduce length of stay (Mean Difference = 0.75, 95% CI - 0.8 to 2.31, P = 0.34, I(2) = 0%). In one study, the only reported side effect of acetazolamide was hypokalemia (nearly 50% in the acetazolami …
Furthermore, our meta-analysis showed that acetazolamide did not reduce length of stay (Mean Difference = 0.75, 95% CI - 0.8 to 2.31, …
361 results

Searches related to "acetazolamide"